Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.

Adagio Medical Holdings, Inc ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been ...

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

Medtronic has announced that Ryan Weispfenning, vice president and head of investor relations, will join its diabetes business to establish and lead the investor relations function ...

AI, machine learning, and cloud platforms are reshaping remote patient monitoring. These technologies support predictive ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Medtronic plc is rated a Buy, expecting 10-11% annual total returns, supported by 7-8% EPS growth. Learn more about MDT stock ...

Switzerland: Adults with type 1 diabetes using CGM and a smart insulin pen achieved higher time in range when they ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

If you are wondering whether Medtronic is still a solid buy at around $101 a share, or if the easy money has already been ...

Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems.